- Field Trip Health & Wellness (FTHW) has launched Field Trip Online Therapy, a unique approach to psychotherapy
- Major insurance providers will be accepting this new offering by Field Trip
- Field Trip Health & Wellness engages in the development and delivery of psychedelic therapies
- Field Trip Health & Wellness Ltd. (FTHW) is down 5.00 per cent, trading at C$0.095 per share at 10:48 am ET
Field Trip Health & Wellness (FTHW) launched Field Trip Online Therapy, a unique approach to psychotherapy.
It leverages contemporary talk therapy, integrative wellness tools and insights derived from being one of the largest global providers of psychedelic-assisted therapies.
Major insurance providers will be accepting this new offering by Field Trip. It is covered by Aetna, Cigna, Blue Cross Blue Shield, Oxford, United Healthcare, and Oscar Health.
The online program will provide a new level of care for anyone seeking therapeutic support to heal their mind, body, and spirit. It is also for people looking to integrate insights and learnings from ketamine infusions or other psychedelic experiences.
Each session will be 53 minutes long and includes talk therapy and additional holistic wellness practices. It includes breathwork, somatic release, visualization, and meditation. The therapist providing this therapy will have completed a proprietary psychotherapy training program developed by Field Trip.
Ronan Levy, Chairman and CEO of Field Trip, commented on the news.
“We are delivering unparalleled mental health results for people who complete our ketamine-assisted therapy. At the same time, we know ketamine therapies are not for everyone. That is why I’m thrilled to introduce our Field Trip Online Therapy program. It brings the unique insights our team has learned from providing psychedelic therapies and translates them into an offering that reaches a wider audience of people at a time when they need it most.”
The program is now available in New York, with plans to roll out to additional states throughout 2023.
Field Trip Health & Wellness engages in the development and delivery of psychedelic therapies. It develops psychedelic molecules and conducts advanced research on plant-based psychedelics.
Field Trip Health & Wellness Ltd. (FTHW) is down 5.00 per cent, trading at C$0.095 per share at 10:48 am ET.
